Dr Chad William Becker, DO | |
1200 Pleasant St, Des Moines, IA 50309-1406 | |
(515) 241-6412 | |
Not Available |
Full Name | Dr Chad William Becker |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 1200 Pleasant St, Des Moines, Iowa |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043679699 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | DO-05356 (Iowa) | Secondary |
207P00000X | Emergency Medicine | 123456 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Chad William Becker, DO 10497 Nw 108th Pl, Granger, IA 50109-9797 Ph: (435) 513-2004 | Dr Chad William Becker, DO 1200 Pleasant St, Des Moines, IA 50309-1406 Ph: (515) 241-6412 |
News Archive
Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, for families nationwide and internationally, said today in an interview of Matthew Schissler, co-founder and CEO, by analyst Francis Gaskins, that its goal is to be the world's largest stem cell storage facility.
Scientists have discovered for the first time a specific biochemical pathway by which the sex hormone, androgen, increases levels of harmful chemicals called reactive oxygen species (ROS) in the prostate gland that play a role in the development of prostate cancer.
A multi-institutional group of researchers, led by investigators at Children's Hospital Los Angeles and the University of Michigan, have identified a simple and inexpensive tool for assessing the prognosis of pediatric brain tumors called ependymomas.
Insilico Medicine, a Baltimore-based Big Data analytics company applying deep learning techniques to drug discovery, biomarker development and human longevity research will present and chair a panel at the BioDataWorld West, San Francisco, April 26-27.
Regulus Therapeutics Inc. today announced that new data from its metabolic disease program were presented at the "Diabetes" Keystone Symposium held April 12-17 in Whistler, British Columbia. The new pre-clinical research findings showed that therapeutic oligonucleotides targeting microRNA are able to improve insulin resistance and normalize plasma glucose in mouse models of diabetes while having no significant effect on glucose or insulin levels in normal mice.
› Verified 9 days ago
Myles Kawamura, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1111 6th Ave, Emergency Department, Des Moines, IA 50314 Phone: 515-247-3211 Fax: 515-643-8933 | |
Brooke Johnson, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 Pleasant St, Des Moines, IA 50309 Phone: 515-241-6262 | |
Hijinio G. Carreon, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1111 6th Ave, Emergency Department, Des Moines, IA 50314 Phone: 515-247-4445 | |
Dr. Kevin Pothoven, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1111 6th Ave, Des Moines, IA 50314 Phone: 515-247-3211 Fax: 515-643-8722 | |
Dr. Anastasia Maria Marx, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 Pleasant St, Des Moines, IA 50309 Phone: 515-241-6212 | |
Dr. Benjamin R Sweet, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1111 6th Ave, Des Moines, IA 50314 Phone: 515-247-3121 |